Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models

Published:2014-03-08 Issue:5 Volume:140 Page:757-767
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Ku Bo Mi,Kim Se-Jin,Kim Nayeon,Hong Dongwan,Choi Yong-Bock,Lee Seon-Hyeong,Gong Young-Dae,Kim Soo-Youl

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-014-1623-5.pdf

Reference33 articles.

1. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A (2013) NCBI GEO: archive for functional genomics data sets-update. Nucl Acids Res 41(Database issue):D991–D995. doi: 10.1093/nar/gks1193

2. Berglind H, Pawitan Y, Kato S, Ishioka C, Soussi T (2008) Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination. Cancer Biol Ther 7(5):699–708. doi: 10.4161/cbt.7.5.5712

3. Choueiri TK (2011) VEGF inhibitors in metastatic renal cell carcinoma: current therapies and future perspective. Curr Clin Pharmacol 6(3):164–168

4. Delhase M, Kim SY, Lee H, Naiki-Ito A, Chen Y, Ahn ER, Murata K, Kim SJ, Lautsch N, Kobayashi KS, Shirai T, Karin M, Nakanishi M (2012) TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc Natl Acad Sci USA 109(4):E177–E186. doi: 10.1073/pnas.1119296109

5. Gong YD, Lee T (2010) Combinatorial syntheses of five-membered ring heterocycles using carbon disulfide and a solid support. J Comb Chem 12(4):393–409. doi: 10.1021/cc100049u

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel combinatorial autophagy inhibition therapy for triple negative breast cancers;European Journal of Pharmacology;2024-06

2. Inhibition of autophagy initiation: A novel strategy for oral squamous cell carcinomas;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-02

3. Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma;Bioorganic Chemistry;2024-02

4. Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2);Journal of Medicinal Chemistry;2023-07-14

5. Transglutaminase 2 regulates terminal erythroid differentiation via cross-linking activity;Frontiers in Cell and Developmental Biology;2023-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3